Lelliottia amnigena: Taxonomy, Genomics, Morphology, and Ecology

Lelliottia amnigena is a Gram-negative, rod-shaped bacterium that was formally separated from the genus Enterobacter in 2013 and placed into the newly created genus Lelliottia. Originally described as Enterobacter amnigenus, the organism had been known for decades as a waterborne coliform found in rivers, lakes, and drinking-water reservoirs. Its reclassification, driven by molecular evidence that the old genus Enterobacter was far too genetically diverse to hold together, reshaped how microbiologists think about an entire branch of the family Enterobacteriaceae. Beyond the name change, research over the past decade has revealed a surprisingly versatile organism: a colonizer of low-nutrient aquatic environments, a plant-growth promoter, an occasional food contaminant, and a rare but real opportunistic pathogen in humans.

How Lelliottia amnigena Got Its Name

For most of its known history, this bacterium went by Enterobacter amnigenus, a name reflecting its frequent isolation from water (“amnigenus” derives from the Latin for “born of a river”). The genus Enterobacter, however, had become a taxonomic dumping ground. Species assigned to it on the basis of older biochemical tests turned out, once DNA-level methods became available, to be only distantly related to one another. A 2013 study used multilocus sequence analysis of four housekeeping genes across the genus and found that Enterobacter split cleanly into five well-supported genetic clusters. The authors proposed three entirely new genera to accommodate the outlying clusters: Lelliottia, Pluralibacter, and Kosakonia. E. amnigenus and its close relative E. nimipressuralis landed in Lelliottia, named in honor of the British microbiologist R.A. Lelliott.

The reclassification was not based on gene sequences alone. Phenotypic characteristics, including sugar fermentation patterns and cell-wall fatty acid profiles, also supported the split. Two biogroups had long been recognized within the species: Biogroup 1 ferments sucrose and raffinose but not D-sorbitol, while Biogroup 2 ferments D-sorbitol but not sucrose or raffinose. These fermentation differences, combined with fatty acid data and molecular phylogenetics, provided the layered evidence needed to justify carving out a separate genus.

Cell Shape, Growth, and Basic Physiology

Under the microscope, L. amnigena looks like most of its Enterobacteriaceae relatives: a small rod-shaped cell with flagella that make it actively motile. It stains Gram-negative, meaning it has a thin peptidoglycan layer sandwiched between an inner and outer membrane. The bacterium is a facultative anaerobe, capable of growing with or without oxygen, which helps explain why it thrives in such a range of environments, from well-oxygenated surface water to the low-oxygen interior of a rotting onion bulb.

Its metabolic flexibility is part of what makes L. amnigena ecologically successful. The two biogroups differ in which sugars they can use as carbon sources, but both are nutritionally undemanding enough to persist in oligotrophic (nutrient-poor) water. The organism also turns up in richer substrates: unpasteurized milk, cream, onions, and cured pork sausages have all yielded isolates.

What the Genome Reveals

A representative genome, sequenced from a strain isolated from the Yamuna River in Delhi, gives a snapshot of the species’ genetic toolkit. The genome spans roughly 4.55 million base pairs across 85 assembled contigs, with a GC content of about 53 percent. It encodes around 4,259 predicted coding sequences, 76 transfer RNAs, 4 ribosomal RNA operons, and close to 2,860 proteins with assigned functions.

⁴

Those numbers place L. amnigena squarely in the typical range for Enterobacteriaceae. Its genome is compact enough to replicate quickly in favorable conditions but large enough to carry genes for diverse metabolic pathways and stress responses. The Yamuna River isolate was specifically flagged for its nitrate tolerance, hinting that some strains carry genetic equipment that helps them cope with polluted water, a trait of practical interest in environmental monitoring.

Comparative genomic work on reservoir and lake isolates has focused on whether the strains harbor virulence factors or clinically relevant antibiotic resistance genes. In a study of 17 environmental coliform isolates, including L. amnigena and L. aquatilis, researchers found that the typical virulence factors seen in pathogenic Enterobacteriaceae were absent. What resistance genes the strains did carry appeared to be of natural, chromosomal origin rather than acquired from clinical settings.

⁵

A Water Bacterium at Heart

The species’ strongest ecological association is with freshwater. L. amnigena appears regularly in rivers, lakes, and drinking-water reservoirs, often alongside Enterobacter asburiae and its sister species Lelliottia aquatilis. In temperate-climate reservoirs, coliform numbers can swing dramatically with the seasons: summer counts may surge to more than 10,000 cells per 100 milliliters, an increase of roughly four orders of magnitude compared to winter. During those warm-season blooms, diversity collapses and just one or two species, frequently E. asburiae or Lelliottia spp., dominate the entire water body.

⁶

These blooms matter for water utilities because coliform detection is a standard regulatory indicator of water quality. When reservoir counts spike, coliforms occasionally slip through treatment and appear in finished drinking water, triggering compliance alerts. Genomic analysis, however, suggests that the reservoir strains are environmental organisms adapted to low-nutrient aquatic life, with no significant hygienic relevance for humans. In other words, detecting L. amnigena in treated water is a treatment-process headache rather than a public-health emergency, though it still forces utilities to investigate and respond.

⁵

Plant Growth Promotion

One of the more unexpected roles for L. amnigena is as a beneficial partner to plants. Two isolates recovered from the rhizosphere of the weed Euphorbia prostrata were tested for a range of plant-growth-promoting traits. Both could produce ammonia, fix atmospheric nitrogen, and synthesize the phytohormones indole-3-acetic acid (IAA) and gibberellic acid. One of the two isolates also solubilized zinc, a micronutrient plants need but often cannot access from soil minerals. Neither isolate produced hydrogen cyanide or formed biofilms in lab conditions, and neither could solubilize potassium.

⁷

When applied to wheat and tomato plants in greenhouse experiments, these strains enhanced overall productivity. The combination of nitrogen fixation, hormone production, and zinc solubilization reads as a promising package for biofertilizer development. The fact that the isolates came from a common weed rather than a crop plant suggests that their growth-promoting abilities are not host-specific. Whether such strains could perform consistently under field conditions, and whether regulatory frameworks would permit their use as inoculants, remain open questions, but the lab results are encouraging enough to put L. amnigena on the radar for sustainable agriculture researchers.

Soft Rot and Quorum Sensing

L. amnigena is not exclusively beneficial to plants, though. Certain strains cause soft rot, a mushy, foul-smelling decay of plant tissue. Onion bulbs have been identified as one host for this kind of damage. Like many soft-rot pathogens, the bacterium coordinates its attack through quorum sensing, a cell-to-cell chemical signaling system that lets a bacterial population “decide” collectively when its numbers are high enough to overwhelm a host’s defenses. Only when signal molecules reach a threshold concentration do the bacteria switch on production of tissue-degrading enzymes.

Interestingly, another common environmental bacterium, Pseudomonas aeruginosa, can disrupt this process. An ethyl acetate extract from a P. aeruginosa strain was shown to inhibit biofilm formation and quorum-sensing-regulated virulence factors in a soft-rot strain of L. amnigena. The active compounds turned out to be cyclic dipeptides, small ring-shaped molecules that interfere with the pathogen’s signaling during its active growth phase. At higher concentrations, the extract also directly inhibited growth.

⁸

This kind of interspecies chemical warfare is common in the microbial world, but it has practical implications. If P. aeruginosa-derived compounds can shut down L. amnigena‘s quorum sensing, they might be developed into biocontrol agents that protect crops without conventional pesticides. The research is still at the proof-of-concept stage, but it illustrates how studying even obscure organisms can open up new agricultural tools.

Opportunistic Infections in Humans

For most healthy people, L. amnigena is harmless. The organism lacks the hallmark virulence factors carried by aggressive human pathogens in the Enterobacteriaceae, and its primary habitat is environmental water rather than the human gut. But like many environmental bacteria, it can occasionally cause disease in people whose immune defenses are compromised.

Published case reports describe L. amnigena infections in patients with underlying conditions such as cirrhosis and poorly controlled diabetes. In one case, a woman with both of those risk factors developed acute calculous cholecystitis (an inflamed, stone-containing gallbladder) from which L. amnigena was cultured from the bile.

⁹ Another report documented L. amnigena co-infection with Pseudomonas putida in a critically ill patient with severe COVID-19.

These infections are rare enough that each one tends to generate a published case report. That rarity itself is informative: L. amnigena is widespread in water and food, so the fact that human infections are so uncommon reinforces the genomic evidence that environmental strains simply are not equipped to attack a healthy immune system. Still, for clinicians managing immunocompromised patients, knowing that this organism exists and can occasionally behave as a pathogen matters for diagnosis and treatment decisions.

Antibiotic Resistance and the LAQ-1 Enzyme

When L. amnigena does cause an infection, treatment is complicated by a resistance profile that mirrors what you would expect from an Enterobacteriaceae member with an inducible chromosomal beta-lactamase. A strain designated P13 was found to carry a novel class C beta-lactamase, named LAQ-1, on its chromosome. When the gene for LAQ-1 was cloned and expressed in a susceptible lab strain, it raised resistance levels by roughly 4- to 64-fold against a range of cephalosporins, from first-generation drugs like cefazolin through the fourth-generation cefepime. Classic beta-lactamase inhibitors such as clavulanic acid and sulbactam had poor inhibitory effects against LAQ-1.

On the positive side, LAQ-1 did not confer resistance to carbapenems, which remain a last-resort antibiotic class. The P13 strain also carried a separate plasmid-borne resistance gene, bla_TEM-1, adding another layer of beta-lactam resistance on top of the chromosomal enzyme. The combination of a chromosomal AmpC-type enzyme and a plasmid-acquired TEM-type enzyme is a familiar pattern in Enterobacteriaceae, but its documentation in L. amnigena specifically is relatively new. For clinical labs that encounter this organism, the take-home message is to test susceptibility carefully rather than assume that standard beta-lactam/inhibitor combinations will work.

Food Contamination and Safety Context

L. amnigena shows up in the food supply more often than you might expect for a “water bacterium.” Isolates have been recovered from onions, cream, unpasteurized milk, and Spanish pork sausages.

³ In most of these contexts the organism is probably a contaminant from the water or processing environment rather than a natural inhabitant of the food itself. Onions are the exception: here the bacterium actively invades tissue and causes soft rot, so its presence reflects a genuine plant disease rather than passive contamination.

For consumers, finding L. amnigena in food is not on the same level as finding Salmonella or Listeria. There are no documented outbreaks of foodborne illness traced to this species. Its appearance in food-safety literature is more about completeness of microbial surveillance than about a recognized hazard. That said, in a hospital food-service setting where immunocompromised patients are eating, even low-virulence organisms deserve attention. Pasteurization, proper refrigeration, and standard hygiene measures are more than sufficient to prevent any issues.

The Drinking Water Monitoring Puzzle

The seasonal blooms of L. amnigena and related species in reservoirs create a genuine puzzle for water-quality regulation. Coliform testing was originally designed as an indicator of fecal contamination, with the logic that where you find coliforms, you might also find enteric pathogens. But organisms like L. amnigena are environmental coliforms. They live naturally in surface water, multiply on their own during warm months, and have nothing to do with sewage. When their numbers spike above regulatory thresholds, water utilities are obligated to treat the exceedance as a potential contamination event, even though the genomic evidence points to harmless environmental strains.

⁶

This tension between what the regulation measures and what actually matters for human health is an active area of discussion among water microbiologists. The genomic analysis of reservoir strains, showing no meaningful virulence genes and only natural-origin resistance genes, supports the position that these organisms are not hygienically relevant.

⁵ Some researchers argue that the coliform indicator itself is outdated and should be supplemented or replaced by methods that distinguish fecal from environmental coliforms. Others counter that a conservative regulatory stance protects against unknown risks. Either way, L. amnigena sits right at the center of this debate as one of the most common culprits behind non-fecal coliform exceedances in reservoirs.

Identification Challenges in the Lab

Because L. amnigena was reclassified relatively recently, older automated identification systems in clinical and water-testing laboratories may still report it as Enterobacter amnigenus. The reference databases used by biochemical identification panels sometimes lag behind taxonomic revisions by years. MALDI-TOF mass spectrometry, which identifies bacteria by their protein fingerprint, has improved the situation considerably, but only when the instrument’s database includes up-to-date entries for newer genera like Lelliottia. Labs running older database versions can get a correct species-level match but an outdated genus name, or, worse, a misidentification to a related but different species.

For clinical settings, this matters because misidentification could mean applying the wrong resistance assumptions. If the lab calls it a generic Enterobacter, a clinician might expect one resistance pattern; knowing it is Lelliottia amnigena with its characteristic LAQ-1 enzyme changes the picture. Molecular confirmation via 16S ribosomal RNA gene sequencing or multilocus sequence typing remains the gold standard when identification is uncertain, but these methods are slower and more expensive than routine bench tests.

Open Questions and Current Research Directions

Several threads of L. amnigena research remain loosely woven. On the agricultural side, the plant-growth-promoting isolates have been tested only under controlled greenhouse conditions. Whether they survive well enough in open-field soil to benefit crops, whether they compete with native soil microbes, and whether they interact differently with various crop species are all unanswered. The potential for biofertilizer applications is there, but it needs field validation before it becomes practical.

On the clinical side, the handful of case reports does not provide enough data to say how common L. amnigena infections truly are. Some may go undiagnosed because the organism is misidentified or because clinicians, unfamiliar with the name, do not report the case. As MALDI-TOF databases improve and awareness of the genus grows, the apparent incidence may tick upward without any actual change in how often infections occur. That kind of surveillance artifact is common when organisms get reclassified or when diagnostic tools improve.

Environmental genomics is arguably the most active research front. Groups in Europe and South Asia are sequencing L. amnigena isolates from diverse water bodies, looking at horizontal gene transfer, plasmid content, and how resistance genes move between environmental and clinical strains. The nitrate-tolerant Yamuna River isolate, for instance, raises the question of whether strains from heavily polluted waterways carry different genetic cargo than those from pristine reservoirs. If pollution selects for resistance or virulence traits, that would change the risk calculus for water utilities and regulators alike.

⁴